Abilita Bio
Privately-held US biotech focused on enabling discovery and development of drugs targeting challenging membrane proteins.
The San Diego-based company has partnerships with pharma companies including the biotech major Amgen around its Enabled Membrane Protein technology platform.
Latest Abilita Bio News & Features
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze